0000919574-26-002230.txt : 20260414 0000919574-26-002230.hdr.sgml : 20260414 20260414141611 ACCESSION NUMBER: 0000919574-26-002230 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20260414 DATE AS OF CHANGE: 20260414 EFFECTIVENESS DATE: 20260414 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tridge Life Sciences Fund, LP CENTRAL INDEX KEY: 0002125722 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-580356 FILM NUMBER: 26860348 BUSINESS ADDRESS: STREET 1: 405 LEXINGTON AVE, SUITE 809 CITY: NEW YORK STATE: NY ZIP: 10174 BUSINESS PHONE: 989-430-3382 MAIL ADDRESS: STREET 1: 405 LEXINGTON AVE, SUITE 809 CITY: NEW YORK STATE: NY ZIP: 10174 D 1 primary_doc.xml X0708 D LIVE 0002125722 Tridge Life Sciences Fund, LP 405 LEXINGTON AVENUE SUITE 809 NEW YORK NY NEW YORK 10174 989-430-3382 DELAWARE None None Limited Partnership true 2025 - Tridge Capital Management, LLC 405 LEXINGTON AVENUE SUITE 809 NEW YORK NY NEW YORK 10174 Executive Officer Promoter Investment Manager - Tridge Capital GP, LLC 405 LEXINGTON AVENUE SUITE 809 NEW YORK NY NEW YORK 10174 Executive Officer Promoter General Partner Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.1 false true true true true false 0 Indefinite 0 Indefinite false 0 0 true 0 true 0 true The Investment Manager receives customary management fees. false Tridge Life Sciences Fund, LP /s/ James Tumbrink James Tumbrink Authorized Person 2026-04-14